HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Min-Chuan Huang Selected Research
Min-Chuan Huang Research Topics
Disease
22
Neoplasms (Cancer)
04/2022 - 06/2007
7
Neoplasm Metastasis (Metastasis)
01/2021 - 09/2013
7
Carcinogenesis
06/2017 - 08/2009
7
Neuroblastoma
01/2016 - 09/2010
5
Colorectal Neoplasms (Colorectal Cancer)
06/2014 - 08/2009
4
Adenocarcinoma
01/2021 - 03/2016
3
Colonic Neoplasms (Colon Cancer)
04/2014 - 08/2009
3
Hepatocellular Carcinoma (Hepatoma)
01/2014 - 12/2011
2
Squamous Cell Carcinoma of Head and Neck
01/2021 - 10/2018
2
Melanoma (Melanoma, Malignant)
03/2017 - 01/2016
2
Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 01/2016
1
Emerging Communicable Diseases (Emerging Infectious Diseases)
04/2022
1
Communicable Diseases (Infectious Diseases)
04/2022
1
Head and Neck Neoplasms (Head and Neck Cancer)
01/2021
1
Stomach Neoplasms (Stomach Cancer)
01/2020
1
Hypopigmentation (Hypomelanosis)
03/2017
1
Ovarian Epithelial Carcinoma
01/2016
1
Lymphoma (Lymphomas)
01/2016
1
Breast Neoplasms (Breast Cancer)
03/2015
1
Urinary Bladder Neoplasms (Bladder Cancer)
05/2014
1
Endometrial Neoplasms (Endometrial Cancer)
03/2013
1
Hemangioma (Angioma)
01/2013
1
Choriocarcinoma
10/2007
Drug/Important Bio-Agent (IBA)
14
Mucins
IBA
11/2018 - 10/2007
7
Integrins
IBA
01/2021 - 06/2007
6
Enzymes
IBA
01/2018 - 12/2011
6
Messenger RNA (mRNA)
IBA
03/2015 - 08/2009
5
Polysaccharides (Glycans)
IBA
01/2017 - 09/2013
3
Proteins (Proteins, Gene)
FDA Link
03/2015 - 12/2011
3
Calreticulin
IBA
05/2014 - 09/2010
3
Tumor Viral Antigens (Large T Antigen)
IBA
04/2014 - 01/2013
2
Glycoproteins (Glycoprotein)
IBA
11/2018 - 01/2017
2
ErbB Receptors (EGF Receptor)
IBA
01/2018 - 12/2011
2
Lectins
IBA
01/2017 - 01/2016
2
Antigens
IBA
12/2014 - 12/2013
2
Carbohydrates
IBA
12/2014 - 12/2013
2
poly-N-acetyllactosamine
IBA
06/2014 - 04/2013
1
Pharmaceutical Preparations
IBA
04/2022
1
Cations
IBA
04/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Autoantibodies
IBA
01/2021
1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Nivolumab
IBA
01/2021
1
pembrolizumab
IBA
01/2021
1
EphA1 Receptor (Eph Receptor)
IBA
01/2020
1
Fluorouracil (Carac)
FDA Link
Generic
01/2020
1
Ephrins
IBA
01/2020
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
10/2018
1
Itraconazole (Sporanox)
FDA Link
Generic
10/2018
1
Monophenol Monooxygenase (Tyrosinase)
IBA
03/2017
1
Peptides (Polypeptides)
IBA
03/2017
1
Proto-Oncogene Proteins c-met
IBA
03/2016
1
Glycosyltransferases
IBA
01/2016
1
Glycoside Hydrolases (Endoglycosidases)
IBA
01/2016
1
Thomsen-Friedenreich antigen
IBA
03/2015
1
Catenins
IBA
03/2015
1
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
12/2014
1
Tn antigen
IBA
12/2014
1
N- acetylgalactosaminyl- 1- 4- N- acetylglucosamine
IBA
06/2014
1
Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)
IBA
05/2014
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
04/2014
1
Molecular Chaperones (Chaperone, Molecular)
IBA
02/2014
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
02/2014
1
Focal Adhesion Protein-Tyrosine Kinases
IBA
12/2013
1
Paxillin
IBA
12/2013
1
Phosphotransferases (Kinase)
IBA
09/2013
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
09/2013
1
Toll-Like Receptor 3
IBA
08/2013
1
Epidermal Growth Factor (EGF)
IBA
03/2013
1
Nerve Growth Factor (NGF)
IBA
07/2012
1
Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)
IBA
07/2012
1
Insulin-Like Growth Factor II (Somatomedin A)
IBA
12/2011
1
Carrier Proteins (Binding Protein)
IBA
12/2011
1
Notch1 Receptor
IBA
09/2010
1
Biological Products
IBA
09/2010
1
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
09/2010
1
Mitogen-Activated Protein Kinase 3
IBA
08/2009
1
2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- one
IBA
08/2009
1
matrigel
IBA
10/2007
1
Mitogen-Activated Protein Kinases
IBA
06/2007
Therapy/Procedure
2
Precision Medicine
04/2022 - 01/2021
2
Therapeutics
01/2017 - 01/2016
1
Immunotherapy
01/2021